Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Receivables - Other (2020 - 2024)

Historic Receivables - Other for Silo Pharma (SILO) over the last 5 years, with Q2 2024 value amounting to $9600.0.

  • Silo Pharma's Receivables - Other changed N/A to $9600.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $9600.0, marking a year-over-year change of. This contributed to the annual value of $9600.0 for FY2023, which is 5973.38% up from last year.
  • Latest data reveals that Silo Pharma reported Expense - Property Taxes and Insurance of $21100.0 as of Q3 2024, which was down 1858.0% from $21101.0 recorded in Q2 2024.
  • In the past 5 years, Silo Pharma's Expense - Property Taxes and Insurance registered a high of $33292.0 during Q1 2022, and its lowest value of $3982.0 during Q2 2020.
  • Its 5-year average for Expense - Property Taxes and Insurance is $23207.9, with a median of $23448.0 in 2023.
  • Per our database at Business Quant, Silo Pharma's Receivables - Other surged by 15531.91% in 2021 and then tumbled by 8998.33% in 2022.
  • Over the past 5 years, Silo Pharma's Receivables - Other (Quarter) stood at $23500.0 in 2020, then soared by 155.32% to $60000.0 in 2021, then tumbled by 89.98% to $6010.0 in 2022, then soared by 59.73% to $9600.0 in 2023, then changed by 0.0% to $9600.0 in 2024.
  • Its Receivables - Other was $9600.0 in Q2 2024, compared to $9600.0 in Q1 2024 and $9600.0 in Q4 2023.